cannabidiol and Niemann-Pick-Diseases

The hydrolysis of sphingomyelin in cells derived from a Niemann-Pick patient was studied using both a labelled precursor and measurement of endogenous levels. In vitro exposure of the cells to cannabidiol resulted in a large decrease in both the relative and absolute amounts of this lipid; the drug had a smaller effect on normal fibroblasts. Cannabidiol has been tested in the clinic as an antiepileptic agent with some success; our findings suggest that it may also be useful in relieving the symptoms associated with Niemann-Pick disease.

Topics: Cannabidiol; Cannabinoids; Cells, Cultured; Fibroblasts; Humans; Hydrolysis; Lipid Metabolism; Niemann-Pick Diseases; Sphingomyelins